NIH: A single skills-based class relieves lower back pain … Still no mandate, but Pennsylvania wants 80% of SNF workers vaccinated by October … Federal scientists develop faster COVID-19 test … APIC...
Burden of persistent symptoms high after COVID-19 infection
May 24, 2022
– A high burden of persistent symptoms is observed in persons after COVID-19, but no specific causes of symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)...
NIH: Temperature-stable TB vaccine found safe, effective in trial
By
Alicia Lasek
Mar 07, 2023
A temperature-stable tuberculosis vaccine that lasts for months in storage is safe and effective in healthy adults, according to the results of a new trial.
NIH: ‘Good’ cholesterol may not universally predict heart disease risk
By
Alicia Lasek
Nov 28, 2022
In a study of 23,000 people, high HDL cholesterol levels were not associated with reduced cardiovascular disease risk, and low levels predicted increased heart disease in white but not Black adults.
NIH: Two drugs most effective in treating type 2 diabetes
By
John Roszkowski
Sep 23, 2022
Two popular drugs used to treat type 2 diabetes outperformed other medications in managing glucose levels and keeping people with type 2 diabetes healthy, according to new research funded by the National...
FDA nixes use of Parkinson’s drug Nuplazid for treating Alzheimer’s psychosis
By
Alicia Lasek
Aug 08, 2022
The Food and Drug Administration has decided not to approve an expanded use of the psychosis drug pimavanserin (Nuplazid) to treat patients with Alzheimer’s.
CMS edicts bring tougher survey conditions to nursing homes
By
Danielle Brown
Nov 15, 2021
More oversight is coming for nursing home providers after the Centers for Medicare & Medicaid Services directed surveyors to take a more critical look at nurse competency and residents’ quality of care...
Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.
Feds look to OTC drugs for self-treatment of mild, moderate COVID
By
Alicia Lasek
Apr 21, 2021
A large trial is set to study the potential for repurposed, over-the-counter drugs to treat mild-to-moderate COVID-19 symptoms. If found effective, the approval timeline will likely be short, according...
U.S. invests $1 billion in a vaccine candidate; NIH tests multiple COVID-19 treatments
By
Alicia Lasek
Aug 07, 2020
One hundred million doses of the experimental vaccine will be stockpiled. The deal increases the likelihood that the United States will have at least one safe, effective vaccine by 2021, HHS Secretary...